Toll Free: 1-888-928-9744

Global mRNA Vaccines & Therapeutics Sales Market Report 2017

Published: Aug 8, 2017 | Pages: 113 | Publisher: QYResearch | Industry: Pharmaceutical | Report Format: Electronic (PDF)

In this report, the global mRNA Vaccines & Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of mRNA Vaccines & Therapeutics for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global mRNA Vaccines & Therapeutics market competition by top manufacturers/players, with mRNA Vaccines & Therapeutics sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Argos Therapeutics
    AstraZeneca
    Bayer
    BioNTech
    Boehringer Ingelheim
    CRISPR Therapeutics
    CureVac
    eTheRNA immunotherapies
    Ethris
    GlaxoSmithKline Vaccines
    In-Cell-Art
    Intellia Therapeutics
    Janssen
    Kernal Biologics
    MaxCyte
    Moderna Therapeutics
    Novartis
    PhaseRx
    Precision NanoSystems
    RaNa Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Standardization Of Cancer Treatment MRNA Vaccine
    Individualized Cancer Treatment MRNA Vaccine
    Infectious Disease Treatment MRNA Vaccine
    Infection Prevention MRNA Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of mRNA Vaccines & Therapeutics for each application, including
    Application 1
    Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global mRNA Vaccines & Therapeutics Sales Market Report 2017
1 mRNA Vaccines & Therapeutics Market Overview
    1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
    1.2 Classification of mRNA Vaccines & Therapeutics by Product Category
        1.2.1 Global mRNA Vaccines & Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global mRNA Vaccines & Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Standardization Of Cancer Treatment MRNA Vaccine
        1.2.4 Individualized Cancer Treatment MRNA Vaccine
        1.2.5 Infectious Disease Treatment MRNA Vaccine
        1.2.6 Infection Prevention MRNA Vaccine
    1.3 Global mRNA Vaccines & Therapeutics Market by Application/End Users
        1.3.1 Global mRNA Vaccines & Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.1 Application 1
        1.3.2 Application 2
    1.4 Global mRNA Vaccines & Therapeutics Market by Region
        1.4.1 Global mRNA Vaccines & Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
        1.4.3 China mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
        1.4.4 Europe mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
        1.4.5 Japan mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
        1.4.6 Southeast Asia mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
        1.4.7 India mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of mRNA Vaccines & Therapeutics (2012-2022)
        1.5.1 Global mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2022)

2 Global mRNA Vaccines & Therapeutics Competition by Players/Suppliers, Type and Application
     2.1 Global mRNA Vaccines & Therapeutics Market Competition by Players/Suppliers
        2.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global mRNA Vaccines & Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global mRNA Vaccines & Therapeutics (Volume and Value) by Type
        2.2.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2012-2017)
        2.2.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2012-2017)
    2.3 Global mRNA Vaccines & Therapeutics (Volume and Value) by Region
        2.3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Region (2012-2017)
        2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Region (2012-2017)
    2.4 Global mRNA Vaccines & Therapeutics (Volume) by Application

3 United States mRNA Vaccines & Therapeutics (Volume, Value and Sales Price)
    3.1 United States mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
        3.1.1 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
        3.1.2 United States mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
        3.1.3 United States mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
    3.2 United States mRNA Vaccines & Therapeutics Sales Volume and Market Share by Players
    3.3 United States mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
    3.4 United States mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

4 China mRNA Vaccines & Therapeutics (Volume, Value and Sales Price)
    4.1 China mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
        4.1.1 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
        4.1.2 China mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
        4.1.3 China mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
    4.2 China mRNA Vaccines & Therapeutics Sales Volume and Market Share by Players
    4.3 China mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
    4.4 China mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

5 Europe mRNA Vaccines & Therapeutics (Volume, Value and Sales Price)
    5.1 Europe mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
        5.1.1 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
        5.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
        5.1.3 Europe mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
    5.2 Europe mRNA Vaccines & Therapeutics Sales Volume and Market Share by Players
    5.3 Europe mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
    5.4 Europe mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

6 Japan mRNA Vaccines & Therapeutics (Volume, Value and Sales Price)
    6.1 Japan mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
        6.1.1 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
        6.1.2 Japan mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
        6.1.3 Japan mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
    6.2 Japan mRNA Vaccines & Therapeutics Sales Volume and Market Share by Players
    6.3 Japan mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
    6.4 Japan mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

7 Southeast Asia mRNA Vaccines & Therapeutics (Volume, Value and Sales Price)
    7.1 Southeast Asia mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
        7.1.1 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
    7.2 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume and Market Share by Players
    7.3 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
    7.4 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

8 India mRNA Vaccines & Therapeutics (Volume, Value and Sales Price)
    8.1 India mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
        8.1.1 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
        8.1.2 India mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
        8.1.3 India mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
    8.2 India mRNA Vaccines & Therapeutics Sales Volume and Market Share by Players
    8.3 India mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
    8.4 India mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

9 Global mRNA Vaccines & Therapeutics Players/Suppliers Profiles and Sales Data
    9.1 Argos Therapeutics
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 AstraZeneca
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 AstraZeneca mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Bayer
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Bayer mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 BioNTech
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Boehringer Ingelheim
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 CRISPR Therapeutics
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 CureVac
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 eTheRNA immunotherapies
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Ethris
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 GlaxoSmithKline Vaccines
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 In-Cell-Art
    9.12 Intellia Therapeutics
    9.13 Janssen
    9.14 Kernal Biologics
    9.15 MaxCyte
    9.16 Moderna Therapeutics
    9.17 Novartis
    9.18 PhaseRx
    9.19 Precision NanoSystems
    9.20 RaNa Therapeutics

10 mRNA Vaccines & Therapeutics Maufacturing Cost Analysis
    10.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
    10.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 mRNA Vaccines & Therapeutics Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of mRNA Vaccines & Therapeutics Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global mRNA Vaccines & Therapeutics Market Forecast (2017-2022)
    14.1 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global mRNA Vaccines & Therapeutics Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global mRNA Vaccines & Therapeutics Price and Trend Forecast (2017-2022)
    14.2 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global mRNA Vaccines & Therapeutics Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2017-2022)
       14.3.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2017-2022)
       14.3.3 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2017-2022)
    14.4 Global mRNA Vaccines & Therapeutics Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer


List of Tables and FiguresList of Tables and Figures

    Figure Product Picture of mRNA Vaccines & Therapeutics
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Comparison (K Units) by Type (2012-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
    Figure Standardization Of Cancer Treatment MRNA Vaccine Product Picture
    Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
    Figure Infectious Disease Treatment MRNA Vaccine Product Picture
    Figure Infection Prevention MRNA Vaccine Product Picture
    Figure Global mRNA Vaccines & Therapeutics Sales Comparison (K Units) by Application (2012-2022)
    Figure Global Sales Market Share of mRNA Vaccines & Therapeutics by Application in 2016
    Figure Application 1 Examples
    Table Key Downstream Customer in Application 1
    Figure Application 2 Examples
    Table Key Downstream Customer in Application 2
    Figure Global mRNA Vaccines & Therapeutics Market Size (Million USD) by Regions (2012-2022)
    Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate (2012-2022)
    Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Global Market Major Players mRNA Vaccines & Therapeutics Sales Volume (K Units) (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) of Key Players/Suppliers (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 mRNA Vaccines & Therapeutics Sales Share by Players/Suppliers
    Figure 2017 mRNA Vaccines & Therapeutics Sales Share by Players/Suppliers
    Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Share by Players/Suppliers (2012-2017)
    Table 2016 Global mRNA Vaccines & Therapeutics Revenue Share by Players
    Table 2017 Global mRNA Vaccines & Therapeutics Revenue Share by Players
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Type (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Share (K Units) by Type (2012-2017)
    Figure Sales Market Share of mRNA Vaccines & Therapeutics by Type (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Growth Rate by Type (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Type (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Type (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Volume (K Units) and Market Share by Region (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Share by Region (2012-2017)
    Figure Sales Market Share of mRNA Vaccines & Therapeutics by Region (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Growth Rate by Region in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Region (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Region in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Region (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2016
    Table Global mRNA Vaccines & Therapeutics Sales Volume (K Units) and Market Share by Application (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Share (%) by Application (2012-2017)
    Figure Sales Market Share of mRNA Vaccines & Therapeutics by Application (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Volume (K Units) by Players (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Players (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Players in 2016
    Table United States mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
    Table United States mRNA Vaccines & Therapeutics Sales Volume (K Units) by Application (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
    Figure China mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure China mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
    Table China mRNA Vaccines & Therapeutics Sales Volume (K Units) by Players (2012-2017)
    Table China mRNA Vaccines & Therapeutics Sales Volume Market Share by Players (2012-2017)
    Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share by Players in 2016
    Table China mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
    Table China mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
    Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
    Table China mRNA Vaccines & Therapeutics Sales Volume (K Units) by Application (2012-2017)
    Table China mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
    Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
    Figure Europe mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure Europe mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Europe mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Sales Volume (K Units) by Players (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Sales Volume Market Share by Players (2012-2017)
    Figure Europe mRNA Vaccines & Therapeutics Sales Volume Market Share by Players in 2016
    Table Europe mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
    Figure Europe mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
    Table Europe mRNA Vaccines & Therapeutics Sales Volume (K Units) by Application (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
    Figure Europe mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
    Figure Japan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Japan mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
    Table Japan mRNA Vaccines & Therapeutics Sales Volume (K Units) by Players (2012-2017)
    Table Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Players (2012-2017)
    Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Players in 2016
    Table Japan mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
    Table Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
    Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
    Table Japan mRNA Vaccines & Therapeutics Sales Volume (K Units) by Application (2012-2017)
    Table Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
    Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
    Figure Southeast Asia mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Southeast Asia mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
    Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume (K Units) by Players (2012-2017)
    Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Players (2012-2017)
    Figure Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Players in 2016
    Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
    Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
    Figure Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
    Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume (K Units) by Application (2012-2017)
    Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
    Figure Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
    Figure India mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure India mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure India mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
    Table India mRNA Vaccines & Therapeutics Sales Volume (K Units) by Players (2012-2017)
    Table India mRNA Vaccines & Therapeutics Sales Volume Market Share by Players (2012-2017)
    Figure India mRNA Vaccines & Therapeutics Sales Volume Market Share by Players in 2016
    Table India mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
    Table India mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
    Figure India mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
    Table India mRNA Vaccines & Therapeutics Sales Volume (K Units) by Application (2012-2017)
    Table India mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
    Figure India mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
    Table Argos Therapeutics Basic Information List
    Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table AstraZeneca Basic Information List
    Table AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure AstraZeneca mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table Bayer Basic Information List
    Table Bayer mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Bayer mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure Bayer mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure Bayer mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table BioNTech Basic Information List
    Table BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure BioNTech mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure BioNTech mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure BioNTech mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table Boehringer Ingelheim Basic Information List
    Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table CRISPR Therapeutics Basic Information List
    Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table CureVac Basic Information List
    Table CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure CureVac mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure CureVac mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure CureVac mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table eTheRNA immunotherapies Basic Information List
    Table eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table Ethris Basic Information List
    Table Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Ethris mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure Ethris mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure Ethris mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table GlaxoSmithKline Vaccines Basic Information List
    Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
    Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Global Market Share (2012-2017
    Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Revenue Global Market Share (2012-2017)
    Table In-Cell-Art Basic Information List
    Table Intellia Therapeutics Basic Information List
    Table Janssen Basic Information List
    Table Kernal Biologics Basic Information List
    Table MaxCyte Basic Information List
    Table Moderna Therapeutics Basic Information List
    Table Novartis Basic Information List
    Table PhaseRx Basic Information List
    Table Precision NanoSystems Basic Information List
    Table RaNa Therapeutics Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
    Figure Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
    Figure mRNA Vaccines & Therapeutics Industrial Chain Analysis
    Table Raw Materials Sources of mRNA Vaccines & Therapeutics Major Players in 2016
    Table Major Buyers of mRNA Vaccines & Therapeutics
    Table Distributors/Traders List
    Figure Global mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Price (USD/Unit) and Trend Forecast (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Regions in 2022
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Regions in 2022
    Figure United States mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure China mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure China mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2017-2022)
    Figure Europe mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure Europe mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure India mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure India mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Type (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Type (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) Forecast by Type (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demand

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify